Birdwatch Note Rating
2024-11-29 11:27:34 UTC - NOT_HELPFUL
Rated by Participant: 5761D9B1C167F16BFA8F7F3C9BB26E2B7F5FBACD2F1275BFB39D40E7295E4F4D
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details